Related Experiment Video

Updated: Jul 16, 2026

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
08:46

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives

Published on: September 16, 2021

Fertility drugs and gynecologic cancer

Nikos Kanakas1, Themis Mantzavinos

  • 1In Vitro Fertilization Unit, Euromedica, Athens, Greece. nkanakas@hol.gr

Annals of the New York Academy of Sciences
|February 20, 2007
PubMed

Insights

Fertility drugs (FD) are widely used, prompting cancer risk reviews. Recent studies indicate no significant association between ovulation induction drugs and most cancers, easing safety concerns for fertility treatments.

Area of Science:

  • Reproductive endocrinology and oncology.

Background:

  • Fertility drugs (FD) are increasingly used globally for ovulation induction.
  • Concerns exist regarding potential cancer risks due to elevated gonadal hormones from FD used in treatments like in vitro fertilization (IVF).

Purpose of the Study:

  • To review recent scientific literature on the association between fertility drug use and cancer risk.
  • To evaluate the safety profile of ovulation induction medications in relation to various cancer types.

Main Methods:

  • Systematic review of published studies investigating fertility drugs and cancer incidence.
  • Analysis of research examining drugs such as human chorionic gonadotropin (hCG), human menopausal gonadotropin (hMG), and recombinant follicle-stimulating hormone (rFSH).

Main Results:

  • Multiple studies show no definitive link between fertility drug use and the majority of cancer types.
  • Specific focus on cancers of the breast, ovary, and endometrium did not reveal a consistent association.

Conclusions:

  • Current evidence suggests that fertility drugs, including those used in IVF, are not significantly associated with an increased risk of most cancers.
  • Further research may be warranted, but existing data support the general safety of these medications regarding cancer development.

More Related Videos

Stereotactic Radiosurgery for Gynecologic Cancer10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

Related Concept Videos

Infertility in Females01:28

Infertility in Females

Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of endometrial...
Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Oogenesis02:07

Oogenesis

In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...